Time span | Parameter | Crude hazard rate (95% CI) | p Value | Adjusted hazard rate (95% CI) | p Value |
---|---|---|---|---|---|
0–7 days | Sex | ||||
Female (reference) | 1 | 1 | |||
Male | 0.85 (0.74 to 0.98) | 0.029 | 1.08 (0.93 to 1.25) | 0.302 | |
Age (continuous) | 1.05 (1.04 to 1.05) | <0.001 | 1.04 (1.04 to 1.05) | <0.001 | |
Charlson Comorbidity Index | |||||
0 (reference) | 1 | 1 | |||
1–2 | 3.22 (2.68 to 3.86) | <0.001 | 1.42 (1.17 to 1.72) | <0.001 | |
>2 | 4.75 (3.95 to 5.72) | <0.001 | 1.55 (1.26 to 1.90) | <0.001 | |
Weeks admitted to hospital 180 days prior to first contact | 1.15 (1.12 to 1.18) | <0.001 | 1.08 (1.04 to 1.12) | <0.001 | |
Response time (continuous) | 0.97 (0.96 to 0.99) | <0.001 | 1.00 (0.99 to 1.02) | 0.539 | |
8–30 days | Sex | ||||
Female (reference) | 1 | 1 | |||
Male | 0.93 (0.78 to 1.11) | 0.442 | 1.14 (0.96 to 1.37) | 0.136 | |
Age (continuous) | 1.05 (1.05 to 1.06) | <0.001 | 1.04 (1.04 to 1.05) | <0.001 | |
Charlson Comorbidity Index | |||||
0 (reference) | 1 | 1 | |||
1–2 | 5.10 (3.90 to 6.68) | <0.001 | 2.22 (1.67 to 2.94) | <0.001 | |
>2 | 11.65 (9.00 to 15.08) | <0.001 | 3.59 (2.71 to 4.77) | <0.001 | |
Weeks admitted to hospital 180 days prior to first contact | 1.21 (1.18 to 1.24) | <0.001 | 1.13 (1.10 to 1.17) | <0.001 | |
Response time (continuous) | 0.98 (0.96 to 0.99) | 0.006 | 1.01 (0.99 to 1.03) | 0.266 | |
31–90 days | Sex | ||||
Female (reference) | 1 | 1 | |||
Male | 0.98 (0.83 to 1.15) | 0.813 | 1.22 (1.03 to 1.44) | 0.019 | |
Age (continuous) | 1.05 (1.05 to 1.06) | <0.001 | 1.04 (1.04 to 1.05) | <0.001 | |
Charlson Comorbidity Index | |||||
0 (reference) | 1 | 1 | |||
1–2 | 5.88 (4.57 to 7.57) | <0.001 | 2.51 (1.92 to 3.26) | <0.001 | |
>2 | 13.19 (10.33 to 16.84) | <0.001 | 3.93 (3.01 to 5.14) | <0.001 | |
Weeks admitted to hospital 180 days prior to first contact | 1.23 (1.21 to 1.25) | <0.001 | 1.17 (1.14 to 1.20) | <0.001 | |
Response time (continuous) | 0.96 (0.94 to 0.97) | <0.001 | 0.99 (0.97 to 1.01) | 0.178 | |
91 days–2 years | Sex | ||||
Female (reference) | 1 | 1 | |||
Male | 0.97 (0.88 to 1.05) | 0.429 | 1.22 (1.11 to 1.33) | <0.001 | |
Age (continuous) | 1.05 (1.05 to 1.06) | <0.001 | 1.04 (1.04 to 1.05) | <0.001 | |
Charlson Comorbidity Index | |||||
0 (reference) | 1 | 1 | |||
1–2 | 5.64 (4.96 to 6.43) | <0.001 | 2.54 (2.22 to 2.91) | <0.001 | |
>2 | 14.19 (12.50 to 16.11) | <0.001 | 4.44 (3.86 to 5.10) | <0.001 | |
Weeks admitted to hospital 180 days prior to first contact | 1.21 (1.20 to 1.23) | <0.001 | 1.13 (1.12 to 1.15) | <0.001 | |
Response time (continuous) | 0.96 (0.96 to 0.97) | <0.001 | 1.00 (0.99 to 1.00) | 0.292 |
MECU, mobile emergency care unit.